Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes
Date
2014Author
Osmanbasoglu, O. A.
Ozkaya, H. M.
Demirok, A.
Ozkaya, A.
Alkin, Z.
Metadata
Show full item recordAbstract
Purpose. - To evaluate the efficiency fo intravitreal ranibizumb for the treatment of neovascular age-related macular degeneration (nAMD) patients with a visual acuity (VA) of >= 20/40 and to investigate the predictive factors for visual outcomes.
Collections
- Makale [92796]